A 12-Week Safety Extension Study of Oral ELND005

This study is enrolling participants by invitation only.

Sponsor:

Collaborator:

Elan Pharmaceuticals

Information provided by (Responsible Party):

Elan Pharmaceuticals ( Elan Pharma International Limited )

ClinicalTrials.gov Identifier:

NCT01766336

First received: January 8, 2013

Last updated: May 8, 2013

Last verified: May 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is enrolling participants by invitation only.
Estimated Study Completion Date:	April 2014
Estimated Primary Completion Date:	February 2014 (Final data collection date for primary outcome measure)